PipelineReview.com4h
Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy for Dry Age-related Macular Degeneration
HAYWARD, CA, USA I February 28, 2025 I Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the ...
PipelineReview.com23h
Magnet Biomedicine Enters into a Collaboration and License Agreement with Lilly to Discover and Develop Novel Molecular Glue Medicines
BOSTON, MA, USA I February 28, 2025 I Magnet Biomedicine, a leading biopharmaceutical company advancing molecular glue discovery with rational selection and ...